论文部分内容阅读
目的分析D-二聚体实验室检查的临床意义。方法 360例常见疾病患者,利用乳胶增强免疫投射比浊法检测患者D-二聚体浓度,分析D-二聚体浓度异常情况。结果脑梗死、深静脉血栓形成、肺栓塞患者D-二聚体异常发生率明显高于其他疾病,D-二聚体浓度较其他疾病明显升高,差异有统计学意义(P<0.01);脑梗死、深静脉血栓形成、肺栓塞患者D-二聚体浓度相比差异无统计学意义(P>0.05)。结论通过D-二聚体浓度检测,利于病情判断。通常心脑血管疾病患者D-二聚体浓度升高明显,通过动态观察患者D-二聚体浓度,利于病情预后判断。
Objective To analyze the clinical significance of D-dimer laboratory test. Methods A total of 360 patients with common diseases were enrolled in this study. D-dimer concentration was measured by latex enhanced immunoprecipitation turbidimetry. The abnormality of D-dimer concentration was analyzed. Results The incidence of D-dimer abnormalities in patients with cerebral infarction, deep venous thrombosis and pulmonary embolism was significantly higher than that of other diseases. The D-dimer concentration was significantly higher than other diseases (P <0.01). There was no significant difference in D-dimer concentration between cerebral infarction, deep vein thrombosis and pulmonary embolism (P> 0.05). Conclusion Through the D-dimer concentration test, conducive to disease judgment. Usually D-dimer levels in patients with cardiovascular and cerebrovascular diseases increased significantly by dynamically observing the patient’s D-dimer concentration, which will help determine the prognosis of the disease.